Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Link
http://www.nature.com/articles/cgt201469.pdf
Reference55 articles.
1. Nayak S, Herzog RW . Progress and prospects: immune responses to viral vectors. Gene Therapy 2010; 17: 295–304.
2. Najjar AM, Moyes JS, Cooper LJN . DNA plasmids for non-viral gene therapy of cancer. In: Brenner MK, Hung M-C (eds) Cancer Gene Therapy by Viral and Non-Viral Vectors. John Wiley & Sons, 2014 pp 39–59.
3. Yin H, Kan asty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG . Non-viral vectors for gene-based therapy. Nat Rev Genet 2014; 15: 541–555.
4. Ehrhardt A, Xu H, Huang Z, Engler JA, Kay MA . A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase phiC31 and the Sleeping Beauty transposase. Mol Ther 2005; 11: 695–706.
5. Kawakami K . Tol2: a versatile gene transfer vector in vertebrates. Genome Biol 2007; 8: S7.
Cited by 74 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system;PLOS ONE;2024-08-27
2. INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies—Established Findings and Future Priorities;Transplantation and Cellular Therapy;2024-02
3. Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphoblastic Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024
4. Engineered CAR-T cells: An immunotherapeutic approach for cancer treatment and beyond;Advances in Protein Chemistry and Structural Biology;2024
5. Microphysiological systems for solid tumor immunotherapy: opportunities and challenges;Microsystems & Nanoengineering;2023-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3